Relationships between plasma ferritin and aminotransferase profile in haemodialysis patients with hepatitis C virus

Nephrology Dialysis Transplantation

Volumn 11, Issue 9, 1996, Pages 1792-1796

  Caramelo, C ^a   Albalate, M ^a   Bermejillo, T ^a   Navas, S ^b   Ortiz, A ^a   De Sequera, P ^a   Casado, S ^a   Carreno V ^b  

^a Fund Jiménez Díaz   (Spain)

^b Unidad de Hepatolog?a   (Spain)

Author keywords

Aminotransferases; Ferritin; Haemodialysis; Hepatitis C virus

Indexed keywords

AMINOTRANSFERASE; FERRITIN; IRON; VIRUS RNA;

ADULT; AGED; ARTICLE; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTIOUS COMPLICATION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0029795015     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027670     Document Type: Article

References (23)

1. Roth D. Hepatitis C virus: The nephrologist's view. Am J Kidney Dis 1995; 25: 3-16
2. Vanderpoel C, Cuypers HT, Reesink W. Hepatitis C virus: six years on. Lancet 1994; 344: 1475-1479
3. Esforzado N, Cases A, Barrera JM et al. Prevalencia y factores de riesgo de infection por virus de la hepatitis C en una población de hemodiálisis. Nefrología 1991; 11: 345-348
4. Caramelo C, Ortiz A, Aguilera B et al. Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus. Am J Kidney Dis 1993; 22: 822-828
5. Hu KQ, Vierling J. Molecular diagnostic techniques for viral hepatitis. Gastroenterol Clin North Am 1994; 23: 479-498
6. Perez R, Pravia R, Linares A et al. Response related factors in recombinant interferon alfa-2b treatment of chronic hepatitis C. Gut 1993; 34 [Suppl 2]: S139-140
7. Muller GY, Zabaleta ME, Arminio A et al. Risk factors for dialysis-associated hepatitis C in Venezuela. Kidney Int 1992; 41: 1055-1058
8. Wolf PL, Williams P, Coplon N, Coulson AS. Low aspartate transaminase activity in serum of patients undergoing chronic hemodialysis. Clin Chem 1972; 18: 567-569
9. Vaziri ND, Kim I. Serum enzyme levels. In: Daugirdas JE, Ing TS, eds. Handbook of Dialysis. Little Brown, Boston, 1994; 416-421
10. Ali M, Fayemi O, Rigolosi R, Fascino J, Marsen T, Malcolm D. Hemosiderosis in hemodialysis patients. JAMA 1980; 244: 343-345
11. Clemente MG, Congia M, Lai ME et al. Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C. J Pediatr 1994; 125: 123-128
12. Hayashi H, Takikawa T, Nishimura N, Yano M, Isomura T, Sakamoto N. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol 1994; 89: 986-988
13. Caramelo C, Cannata JB, Rodeles MR et al. Mechanisms of aluminum induced microcytosis: lessons from a case of aluminum intoxication. Kidney Int 1995; 47: 168-172
14. Knodell RG, Ismak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 432-435
15. Tong MJ, Lee SY, Hwang SJ et al. Evidence for hepatitis C viral infection in patients with primary hepatocellular carcinoma. West J Med 1994; 160: 133-138
16. Brunson ME, Lau JY, Davis GL, Scornik J, Howard RJ, Pfaff WW. Non-A, non-B hepatitis and elevated serum aminotransferases in renal transplant patients. Correlation with hepatitis C infection. Transplantation 1993; 56: 1364-1367
17. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurement of iron status in patients with chronic hepatitis. Gastroenterology 1992; 102: 2108-2113
18. Olynyk JK, Rajender K, Di Bisceglie AM et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995; 108: 1104-1109
19. Barton AL, Banner BF, Cable EE, Bonkovsky HL. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy. Am J Clin Pathol 1995; 103: 419-424
20. Rosser B, Gores G. Liver cell necrosis: cellular mechanisms and clinical implications. Gastroenterology 1995; 108: 252-275
21. Sherlock S. Iron overload states. In Sherlock S. Diseases of the Liver and Biliary System. Oxford 1989; 449-459
22. Farinati F, Cardin R, De Maria N et al. J Hepatol 1995; 22: 449-456
23. Fishbane S, Maesaka J. Factors predictive of suboptimal iron stores in hemodialysis patients with normal iron stores. J Am Soc Nephrol 1995; 6: 529 (Abstract)